PGI9 SURGERY-RELATED COSTS AVERTED BY THE USE OF BIOLOGIC DRUGS FOR THE TREATMENT OF CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE CALCULATED THROUGH A MATHEMATICAL MODEL
Abstract
Authors
M.C.L.D. Santos R.P. Rosim M.L. Rachid C. Fioratti T.C. Decimoni M.J. Brunelli